Vivet Therapeutics SAS
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease
Phase 1
Active, not recruiting
- Conditions
- Wilson's Disease
- Interventions
- Genetic: VTX-801
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Vivet Therapeutics SAS
- Target Recruit Count
- 4
- Registration Number
- NCT04537377
- Locations
- 🇺🇸
UC Davis Medical Center, Sacramento, California, United States
🇺🇸Yale University School of Medecine, New Haven, Connecticut, United States
🇺🇸Advent Health, Orlando, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath